´ëÇѽÅÀåÇÐȸ Á¦13ȸ Nephrology Board Review Course 2019 : 2019-02-10±³À°ÀÏÀÚ : 2019-02-10
±³À°Àå¼Ò : ¼¿ï, ¹é¹ü±è±¸±â³ä°ü (¿ë»ê±¸ ÀÓÁ¤·Î 26 ¼ÒÀç)
±³À°ÁÖÁ¦ :
Á¦13ȸ Nephrology Board Review Course 2019 ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
´ã´çÀÚ : »ç¹«±¹ ¿¬¶ôó
¿¬¶ôó : 02-3486-8736
À̸ÞÀÏ :
ksn@ksn.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 80,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02-10 ÄÁº¥¼ÇȦ 09:40~10:05 ATN vs. AIN: indication of kidney biopsy and management ±è¸í±Ô(°í·ÁÀÇ´ë)
±³À°½Ã°£ 02-10 ÄÁº¥¼ÇȦ 10:05~10:35 Non dialytic management of AKI ½ÅÈ£½Ä(°í½ÅÀÇ´ë)
±³À°½Ã°£ 02-10 ÄÁº¥¼ÇȦ 10:35~11:05 The role of CRRT in critically ill patients: renal support vs. renal replacement ÀÌÇϸ°(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 02-10 ÄÁº¥¼ÇȦ 11:05~11:30 Renocardiac vs. cardiorenal syndrome: use of RAS inhibitor in HF patients with AKI ÀåÇý·Ã(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 02-10 ÄÁº¥¼ÇȦ 12:40~13:05 Basic HD essentials: principles and HD modalities. ¹ÚÁ¾ÇÏ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 02-10 ÄÁº¥¼ÇȦ 13:05~13:30 Vascular access: what nephrologists need to know? ³ª±â·®(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 02-10 ÄÁº¥¼ÇȦ 13:30~13:55 Optimizing anemia management in dialysis patients ±è¼öÇö(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 02-10 ÄÁº¥¼ÇȦ 13:55~14:20 Comparison of hemodiafiltration and hemodialysis ±è⼺(Àü³²ÀÇ´ë)
±³À°½Ã°£ 02-10 ÄÁº¥¼ÇȦ 14:20~14:45 Prescription of PD modality: case-based approach µµÁØ¿µ(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 02-10 ÄÁº¥¼ÇȦ 14:45~15:10 How to assess and manage volume status in PD ÃÖÁö¿µ(°æºÏÀÇ´ë)
±³À°½Ã°£ 02-10 ÄÁº¥¼ÇȦ 15:20~15:45 Transplant immunology & relevant immunosuppressive agents Çѽ¼®(¼¿ïÀÇ´ë)
±³À°½Ã°£ 02-10 ÄÁº¥¼ÇȦ 15:45~16:10 Recipient-donor evaluation and ethical issues ÀÌ ½Ä(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 02-10 ÄÁº¥¼ÇȦ 16:10~16:35 Optimal approach of highly sensitized patients ÀÌ»óÈ£(°æÈñÀÇ´ë)
±³À°½Ã°£ 02-10 ÄÁº¥¼ÇȦ 16:35~17:00 Infectious issues in short- and long-term transplant periods ½Åº´Ã¶(Á¶¼±ÀÇ´ë)